← Leaderboards
Edward P Ingenito
Brigham And Women'S Hospital
$10,382,683
Attributed
$12,068,791
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$12,068,791 · 7
By mechanism
R01$10,273,949 · 4
R44$855,484 · 1
P01$844,358 · 1
R43$95,000 · 1
Top collaborators
- Andrew Hoffman5 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Merry L Lindsey$12,766,097
- Benjamin D Humphreys$13,400,455
- Jeremy S Duffield$3,651,673
- Stacey Ann Missmer$8,921,131
- Ali Tamayol$3,768,258
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungResponseSitePulmonary EmphysemaPropertyTissuesStructure Of Parenchyma Of LungBaseMechanicsAlveolarSheepCellsPhysiologicalStem CellsPerfusionNatural RegenerationScaffoldElastic FiberMesenchymalBiopsyCellularityAutologousTissue RegenerationGrowth Factor
Grant awards (27)
Autologous Lung Multipotent Stromal Cell Therapy for Emphysema$295,439
R01 · FY2017 · HL · contact PI
Autologous Lung Multipotent Stromal Cell Therapy for Emphysema$580,117
R01 · FY2016 · HL · contact PI
Autologous Lung Multipotent Stromal Cell Therapy for Emphysema$816,611
R01 · FY2015 · HL · contact PI
Autologous Lung Multipotent Stromal Cell Therapy for Emphysema$818,761
R01 · FY2014 · HL · contact PI
Autologous Lung Multipotent Stromal Cell Therapy for Emphysema$861,288
R01 · FY2013 · HL · contact PI
Pneumografting - a novel cell-based therapy for emphysema$581,206
R01 · FY2010 · HL · contact PI
Pneumografting - a novel cell-based therapy for emphysema$591,689
R01 · FY2009 · HL · contact PI
Pneumografting - a novel cell-based therapy for emphysema$581,083
R01 · FY2008 · HL · contact PI
Pneumografting - a novel cell-based therapy for emphysema$21,000
R01 · FY2008 · HL · contact PI
Pneumografting - a novel cell-based therapy for emphysema$583,728
R01 · FY2007 · HL · contact PI
Force Propagation of Emphysema in Vivo$548,124
R01 · FY2007 · HL · contact PI
Pneumoreductive Surfactant Therapy for Emphysema$320,942
R44 · FY2007 · HL · contact PI
Pneumoreductive Surfactant Therapy for Emphysema$70,833
R44 · FY2007 · HL · contact PI
Force Propagation of Emphysema in Vivo$548,958
R01 · FY2006 · HL · contact PI
Responses to Surgical and Bronchoscopic Volume Reduction$472,253
R01 · FY2006 · HL · contact PI
Pneumoreductive Surfactant Therapy for Emphysema$463,709
R44 · FY2006 · HL · contact PI
Force Propagation of Emphysema in Vivo$516,448
R01 · FY2005 · HL
Responses to Surgical and Bronchoscopic Volume Reduction$469,531
R01 · FY2005 · HL
FREE RADICAL INDUCED SURFACTANT DYSFUNCTION IN ACUTE LUNG INJURY$295,706
P01 · FY2005 · HL
Force Propagation of Emphysema in Vivo$520,753
R01 · FY2004 · HL
Responses to Surgical and Bronchoscopic Volume Reduction$455,858
R01 · FY2004 · HL
Pneumedoreductive Surfacant - New Therapy for Emphysema$95,000
R43 · FY2004 · HL
Responses to Surgical and Bronchoscopic Volume Reduction$442,581
R01 · FY2003 · HL
Responses to Surgical and Bronchoscopic Volume Reduction$453,721
R01 · FY2002 · HL
FREE RADICAL INDUCED SURFACTANT DYSFUNCTION IN ACUTE LUNG INJURY$274,326
P01 · FY2002 · HL
FREE RADICAL INDUCED SURFACTANT DYSFUNCTION IN ACUTE LUNG INJURY$274,326
P01 · FY2002 · HL
LUNG VOLUME REDUCTION USING A BRONCHOSCOPIC APPROACH$114,800
R01 · FY2000 · HL